Skip to main content
Figure 4 | Radiation Oncology

Figure 4

From: BAY 87–2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts

Figure 4

Effect of BAY-87-2243 on local tumor control. Dose-response curves after a) BAY-87-2243 combined with radiotherapy with 30 fractions within 6 weeks (RT) and b) BAY-87-2243 combined with fractionated radiochemotherapy with cisplatin (RCT). Symbols: observed local control rates; curves: calculated local tumor control probabilities (TCP); error bars: 95% CI of TCD50.

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us